...
首页> 外文期刊>World Journal of Gastroenterology >Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma
【24h】

Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma

机译:肝细胞癌发病机理中的错配修复基因(hMLH1,hPMS1,hPMS2,GTBP / hMSH6,hMSH2)

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: DNA mismatch repair (MMR) is an important mechanism for maintaining fidelity of genomic DNA. Abnormalities in one or more MMR genes are implicated in the development of many cancers. We investigated the role of expression of MMR genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in hepatocellular carcinogenesis. METHODS: We evaluated the expression level of MMR genes in 33 hepatocellular carcinoma (HCC) cases using the multiplex reverse transcription (RT) PCR assays, as well as in 16 cases of normal adjacent hepatic tissues, β-actin gene was used as an internal control and calibrator for quantification of gene expression. RESULTS: Out of the 33 studied cases, 25 were HCV positive and 30 (90.9%) showed reduced expression in one or more of the studied MMR genes. Reduced expression was found in hMSH2(71.9%), hMLH1 (53.3%), GTBP(51.1%), hPMS2 (33.3%) and hPMS1 (6%). A significant correlation was found between reduced expression of hPMS2 (P = 0.0069) and GTBP (P = 0.0034), hPMS2 and non-cirrhosis (P = 0.0197), hMLH1 and high grade. On the other hand, 57.1%, 50%, 20%, 18.8%, and 6% of the normal tissues distant to tumors showed reduced expression of hMSH2, hMLH1, GTBP, hPMS2, and hPMS1 respectively. Multivariate analysis revealed a significant correlation between the expression level of hMSH2 (P = 0.008), hMLH1 (P = 0.001) and GTBP (P = 0.032) and HCC, between hPMS2, GTBP and HCV-associated HCC (P < 0.001, 0.002). CONCLUSION: Reduced expression of MMR genes seems to play an important role in HCV-associated HCC. hPMS2 is likely involved at an early stage of hepatocarcinogenesis since it was detected in normal adjacent tissues. Reduced expression of hPMS2 provides a growth advantage and stimulates proliferation which encourages malignant transformation in non-cirrhotic HCV-infected patients via acquisition of more genetic damages.
机译:目的:DNA错配修复(MMR)是维持基因组DNA保真度的重要机制。一个或多个MMR基因的异常与许多癌症的发生有关。我们调查了在肝细胞癌发生过程中MMR基因(hMLH1,hPMS1,hPMS2,GTBP / hMSH6,hMSH2)表达的作用。方法:我们使用多重逆转录(RT)PCR方法评估了33例肝细胞癌(HCC)病例中MMR基因的表达水平,以及16例正常邻近肝组织中的β-肌动蛋白基因作为内部定量基因表达的对照和校准物。结果:在33例研究病例中,HCV阳性25例,其中30例(90.9%)表现出一种或多种MMR基因表达降低。在hMSH2(71.9%),hMLH1(53.3%),GTBP(51.1%),hPMS2(33.3%)和hPMS1(6%)中发现表达降低。发现hPMS2(P = 0.0069)和GTBP(P = 0.0034),hPMS2与非肝硬化(P = 0.0197),hMLH1和高表达之间的减少之间存在显着相关性。另一方面,远离肿瘤的正常组织中分别有57.1%,50%,20%,18.8%和6%的hMSH2,hMLH1,GTBP,hPMS2和hPMS1的表达降低。多变量分析显示hMSH2(P = 0.008),hMLH1(P = 0.001)和GTBP(P = 0.032)和HCC的表达水平在hPMS2,GTBP和HCV相关的HCC之间有显着相关性(P <0.001,0.002) 。结论:MMR基因表达降低似乎在HCV相关的HCC中起重要作用。 hPMS2可能参与了肝癌的早期发展,因为它是在正常的相邻组织中检测到的。 hPMS2的表达降低提供了生长优势,并刺激了增殖,从而通过获得更多的遗传损伤而促进了非肝硬化HCV感染患者的恶性转化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号